Search Results 2321-2330 of 16189 for Epilepsy (Partial Onset)
About this study. RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by reducing ...
Cancer researchers in the Department of Neurology at Mayo Clinic are investigating therapeutic approaches to gene therapy to control tumor growth.
During the early ... There are also less common very early (phase 0) and later (phase 4) phases. ... Patients with seizures may be enrolled if well controlled on ...
A Study Assessing the Effectiveness and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women who have Advanced Breast Cancer which ...
Any active neurological condition (including seizure disorder, traumatic brain injury, stroke) that could affect cognitive functioning or brain imaging results ...
This phase II study will test cancer to see if it has a HER2 mutation and, if so, see how HER2 mutated cancer responds to treatment with neratinib.
During the early phases (phases 1 and 2), researchers assess safety ... duration of overall survival [OS]) or adverse events (occurrence of cytokine ...
The primary hypothesis of this study is that overall survival (OS) and/or progression-free survival (PFS) is prolonged in participants who receive pembrolizumab ...
This imaging test helps detect internal injuries and disease by providing cross-sectional images of bones, blood vessels and soft tissues inside the body.
Participation eligibility · Participants diagnosed with Atopic Dermatitis (AD) as defined by the Hanifin and Rajka criteria. · Participants with AD duration of at ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.